Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
about
Characterization of platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in approachMolecular characterizations of glioblastoma, targeted therapy, and clinical results to datePhase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaPDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.Targeting the PDGF signaling pathway in tumor treatmentA simplified approach for the molecular classification of glioblastomasPDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.Methylation profiling identifies 2 groups of gliomas according to their tumorigenesisBetter prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis.Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applicationsFoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor responsePrevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.Platelet-derived growth factor receptor alpha in glioma: a bad seedIn Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas.Biomarker-based prognostic stratification of young adult glioblastomaOligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomasNot all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.Glioma stem cell signaling: therapeutic opportunities and challenges.PDGF and PDGF receptors in glioma.Platelet-derived growth factor in glioblastoma-driver or biomarker?Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.Quantification of PDGFRA alternative transcripts improves the screening for X-PDGFRA fusions by reverse transcriptase-polymerase chain reaction.Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.Glioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRASHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans.Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.
P2860
Q21089666-34DB62DF-F30B-4365-9E50-453A4A5D85C7Q26822717-B32F5E42-B96D-40D3-8A0E-555F7717C71CQ33396181-F2FAC82E-1115-44DB-8AC7-204E6132FA48Q33399939-B31BED40-BC04-4169-A13C-E39862119438Q33414998-851CF34A-9868-4DF6-A8E5-CA9541666398Q33729734-B3A67E25-F8BB-43A1-9E56-643AE8DAD641Q34064466-B163A65B-53AB-47E5-B268-CE4FC68E84CBQ34164924-22AF3651-07DB-4053-9174-90BF77D05834Q34393461-4F177119-48E8-46D7-A6B1-9D1C57702CB0Q34429149-81F411AD-C032-478C-84F3-1AE5183413FCQ34475004-EC5865D2-9200-4A2F-B9B8-33ABDCEC3094Q34480513-A75C54C9-8822-41AC-8744-8B98BF2165F8Q34695556-B56FB6E9-5744-4259-8D06-F4DA8C3A484BQ35008709-1C7B0567-7925-4E5E-903F-44EF2EE1D8D1Q35570177-7C55F0F3-EE58-46B7-8A5B-E26F11CBECB3Q35602148-E7663C24-6CE3-495A-B3AB-4131801FBEF6Q35674906-A09B7304-7006-4501-85CD-6A29094573D1Q35779256-B455ECAF-D2E7-471B-A6BB-A8DBB1253E86Q36344757-2DA9CC9C-4A84-4F13-8BA1-FEC600E6992DQ36348529-F095EB3F-7236-4F25-A6EC-875F7B8DBEDAQ36528159-6F81E7B6-B820-4A59-8F4B-2886270F89ADQ36723791-3AB7AA69-463B-4706-BD2C-283365D81986Q36782664-7DF40EC1-461D-4417-8A52-40660CFD0ED2Q37231529-0F125B27-CC3F-4D49-B65F-823104B6827CQ37407817-065F13BF-9649-4DB7-B77E-2AD27CB9E0C2Q37662100-2BA77AEC-EF36-40EC-A984-E8BD4EA6794DQ37752381-4AAC826D-DD8E-418D-A552-E3C0E67D15F1Q38003175-7EDBF5F0-E21A-4917-82D0-A6902D82DD30Q38262433-C05CC18A-AE8B-4B5C-8C7E-62099EDDAC90Q38838030-3D8009A3-EAE0-4B92-A153-C3D087E1B3F7Q39325255-D4A55939-AEA8-4360-8AC2-A140D2420027Q39682810-DFAE6486-2121-41A9-B817-2B6465967C73Q41156947-48C09D90-3AAF-43A5-A738-8E2D8A368BDFQ41898874-095A43D9-875B-4912-A0DE-53E4DFFF6CCBQ41917289-CF95F2CD-6BFF-404D-BE8A-7812D6DED37BQ43494911-C482BD11-F4B9-4AA3-9EAF-9F3E2BA7AD85Q47109987-3CB472DF-18D7-48A0-A51F-2362B4046F23Q47588695-BA634307-9244-4EC5-A6EC-03F04E1731EAQ47756210-0BA0DC7D-48A6-467D-96D1-6ADDEB4CDA54Q47851037-70C04FDD-E4A8-4A30-A5FC-D64C9F1FB09B
P2860
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@en
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@nl
type
label
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@en
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@nl
prefLabel
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@en
Expression, mutation and copy ...... d its ligand PDGFA in gliomas.
@nl
P2093
P2860
P50
P356
P1476
Expression, mutation and copy ...... nd its ligand PDGFA in gliomas
@en
P2093
A Ashworth
F Milanezi
J S Reis-Filho
M B K Lambros
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605225
P407
P577
2009-08-25T00:00:00Z